your market intelligence analyst
Search Results
Edit Save
3,525 results 08/15/2020 07:19
- Completes first phase in committed investment of US$ 150M (> INR 1000 Cr). - Sri KT Rama Rao, Hon'ble Minister for Industry & Commerce and IT, Government of Telangana inaugurates the facility. HYDERABAD, India, Aug. 15, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the inauguration of its new Research and Technology (R&T) Centre in Hyderabad, India. 08/14/2020 21:24
SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech company Memo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx's therapeutic COVID-19 antibody candidate in a four-month fast-track process. MTx today announces a collaboration with Northway for fast-track cGMP manufacturing of its lead antibody candidate for... 08/14/2020 08:57
The Covid-19 crisis is having an immense impact on every sector, damaging organisations of all sizes. That being said, while the pandemic is undoubtably far from over, there is finally a light at the end of tunnel, with positive signs of recovery appearing across the globe. Deaths and infection rates across Europe are significantly decreasing, global restrictions are continuing to ease and a UK team has recently discovered that dexamethasone is a viable treatment for the sickest patients. Mea... 08/14/2020 07:31
– Senior Vice President of Corporate and Patient Relations recognized as one of the 100 most inspiring people in the life-sciences industry –. SOUTH PLAINFIELD, N.J., August 6, 2020 – PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to announce that its Senior Vice President of Corporate and Patient Relations, Mary Frances Harmon, has been named to PharmaVOICE magazine’s annual list of the most inspiring people in the life sciences industry. 08/14/2020 07:20
COVID-19 has impacted every country around the world since its arrival in late 2019, either directly or indirectly due to its effect on the global economy. However, things are looking up. By the end of 2021, the WHO plans to deliver over 2 billion doses of a Coronavirus vaccine. The scientific research community is making strong ground. As of 22nd July, there are 24 candidate vaccines in clinical evaluation, some of which have already entered the final phase of clinical trials. But this is an... 08/14/2020 07:02
Two-year long project cycles are no longer an option as the pace of change accelerates to meet the demands of fast-changing market conditions. Life sciences companies know that technology can help them drive greater responsiveness from IT teams and suppliers to the changing needs of the business. But agile development needs to extend beyond the IT department, if companies are to see the benefits of faster business transformation, argues Romuald Braun, VP of Strategy for Life Sciences at Ample... 08/14/2020 07:00
LOS ANGELES, Aug. 14, 2020 /PRNewswire/ -- Capsa Healthcare ("Capsa"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has acquired NewRobo Development B.V. and subsidiaries (collectively, "RoboPharma"). RoboPharma, based in Waalwijk, Netherlands, creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe. Capsa is a leading provider of innovative, highly engineered workflow products that increase efficiency a... 08/14/2020 06:56
Earlier this year, the European authorities, EMA, the Heads of Medicines Agencies (HMA) of EU Member States and EC, published a set of key principles[1], outlining a harmonised approach to developing and delivering up-to-date information about medicines online – an important step towards making electronic product information (ePI) a reality for human medicines in the region. 08/14/2020 06:44
Completed $200 million private placement post period. Phase 3 COPD clinical trials planned to start later this year. Pilot clinical study in patients hospitalized with COVID-19 planned to start in the third quarter. Conference Call Today at 9:00 am EDT / 2:00 pm BST. LONDON, UK and RALEIGH, NC, August 14, 2020 – Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therap... 08/14/2020 06:41
· Niclosamide identified as a potent inhibitor of SARS-Cov-2 by Institut Pasteur Korea, with potency >40x higher than remdesivir. · UNION has advanced niclosamide-based program for COVID-19 (UNI911) to clinical development, currently in Phase 1 study. · TFF formulation technology can broaden the possible range of niclosamide formulations and treatments. · Collaboration between UNION and TFF holds potential to make niclosamide treatments available to a broader r... 08/14/2020 06:38
Sabin Vaccine Institute’s New Rising Star Award Presented to Dr. Katherine E. Gallagher. WASHINGTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge. 08/14/2020 06:37
· US approval for BARHEMSYS® for postoperative nausea & vomiting (PONV). · US approval of BYFAVO™ for procedural sedation. · Strategic agreement with Cosmo Technologies providing funding for US commercialization. · Good progress with preparations for US launch in 2H 2020. Cambridge, UK and Indianapolis, US – 13 August 2020: Acacia Pharma Group plc ("Acacia Pharma" or the "Company" and, together with its subsidiaries, the "Group") (EURONEXT: ACPH), a commerc... 08/14/2020 06:34
Tokyo, Japan and London, UK, 13 August 2020 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first half ended 30 June 2020. The full report is attached or can be accessed by clicking here. Operational Highlights for 1H 2020. New global agreement signed with AbbVie – the discovery collaboration and option to license collaboration will initially focus on discovery of novel small molecules targeting... 08/14/2020 06:33
Recruitment on track with 164 patients already treated. Gosselies, Belgium, 13 August 2020 – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing high unmet medical needs in orthopedics and bone diseases, today announces it has been granted EUR 1.0 million in non-dilutive funding from the Directorate-General for Economy, Employment and Research of the Walloon Region, Belgium. 08/14/2020 06:30
● Largest user analysis of its type in a real-world setting. ● Drug-free, at-home treatment helped 81% of patients feel better after three weeks. ● Minimal side effects, no prescription required and Flow can be delivered to your home within 48 hours. London, Wednesday 12 August, 2020 - In the largest user analysis of its type, 81% of patients using a brain stimulation headset and therapy app to treat depression reported feeling better after three weeks, with minimal side effects. 08/14/2020 05:30 has newly added a new research report, Global Antivenom Market 2020 by Manufacturers, Type and Application, Forecast to 2025 is an effectual representation of the market evaluation that highlights information on various aspects which comprise drivers, restraints, trends, opportunities, and forecast to name a few. 08/14/2020 04:56
As per the research report by ZMR, the valuation of the global sports medicine market in 2016 was about USD 5,782.0 million and is projected to attain a value of around USD 7,986.9 million by 2022, at a CAGR of about 8.25% between 2017 and 2022. A healthcare branch, Sports medicine deals with improving the athletic performance of people.

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications